NCT05892731

Brief Summary

In this study, patients with aged-related hearing loss with depression and without depression were evaluated by audiometry (pure tone audiometry and speech audiometry), cognitive function assessment (MMSE scale for simple mental state test, MoCA Scale for Montreal Cognitive Assessment), and depressive symptoms assessment (GDS-15 and HAMD), resting state EEG. The ananlysis of resting state EEG included power spectral density, traceability analysis, functional connectivity, microstate, clustering coefficient, characteristic path length, characteristic path permeability, and compatibility coefficient. EEG signals were used to explore the activation of brain regions and poor connectivity of brain regions affected by cognitive reserve dissonance on the level of brain imaging. This paper innovatively explores the influence of cognitive reserve dissonance on depressive mood in senile deafness by means of audiological assessment, cognitive function assessment, depression symptom assessment, resting state electroencephalography (EEG) and other technical means. Auditory and cognitive cortical activation, functional connectivity of brain regions, small-world attributes and microstates were analyzed in senile deafness with or without depression at the brain imaging level.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 25, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 7, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

June 7, 2023

Status Verified

January 1, 2023

Enrollment Period

2 months

First QC Date

May 25, 2023

Last Update Submit

June 6, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • score of Montreal Cognitive Assessment scale

    The Montreal Cognitive Assessment Scale(MoCA) is an assessment tool used to rapidly screen for cognitive abnormalities. The test included 11 tests in eight cognitive areas, including attention and concentration, executive function, memory, language, visual structure skills, abstract thinking, calculation, and orientation. Total score of 30 points, and the score of high school/technical secondary school or below needs to be added 1 point. Level: Normal 26-30 , mild cognitive impairment(MCI) 18-25, moderate cognitive impairment 10-17, severe cognitive impairment 0-9.

    1 day of enrollment

  • score of Mini-mental State Examination

    Mini-mental State Examination (MMSE) is a scale for screening cognitive impairment and is widely used in dementia screening. The scale is divided into seven aspects, including time orientation, place orientation, immediate memory, attention and gauging, delayed memory, language and visual space. There are 30 items in the scale, with a total score of 30. The scale is 27 to 30 points normal, 21 to 26 points mild cognitive impairment, 10 to 20 points moderate cognitive impairment, and 0 to 9 points severe cognitive impairment.

    1 day of enrollment

Secondary Outcomes (5)

  • pure tone average

    1 day of enrollment

  • speech acceptance threshold

    1 day of enrollment

  • Maximum speech recognition score

    1 day of enrollment

  • score of 15-item Geriatric Depression Scale

    1 day of enrollment

  • score of HAMD scale

    1 day of enrollment

Study Arms (2)

age-related hearing loss with depression

According to Hamilton depression scale, age-related hearing loss patients were divided into two groups, namely age-related hearing loss with depression and age-related hearing loss without depression.

Other: with depression

age-related hearing loss without depression

According to Hamilton depression scale, age-related hearing loss patients were divided into two groups, namely age-related hearing loss with depression and age-related hearing loss without depression.

Other: without depression

Interventions

age-related hearing loss with depression

age-related hearing loss with depression

age-related hearing loss without depression

age-related hearing loss without depression

Eligibility Criteria

Age55 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In this study, PASS 15.0 was used to calculate the sample size, and the number of cases was arranged in a 1:1 ratio. The test efficacy was 1-β = 0.9, the test level was α = 0.05, σ=3.0. 17 cases were required in each group. Considering the 20% shedding rate, 22 cases were required in each group. Consequently, 44 cases of age-related hearing loss were included in this study.

You may qualify if:

  • age ≥55 years, \< 90 years;
  • For patients diagnosed with senile deafness, refering to Expert Consensus on Diagnosis and Intervention of Senile Hearing Loss, 2019 edition.
  • mild, moderate, moderate and severe sensorineural hearing loss;
  • Chinese who can cooperate with all Chinese version evaluation;
  • right-handed;
  • there was no middle ear disease or inner ear disease;
  • there was no bilateral symmetry or sensorineural deafness;
  • there was no severe neurological disease, serious systemic disease, family genetic history, or severe mental disease;
  • there was no experience of hearing aids fitting.

You may not qualify if:

  • pure tone audiometry suggests that the average pure tone hearing threshold (500Hz, 1kHz, 2kHz, 4kHz) is \> 91dB HL;
  • sensorineural hearing loss caused by noise or drugs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-sen Memorial Hospital of Sun Yat-sen University

Guangzhou, Guangdong, 510000, China

Location

MeSH Terms

Conditions

PresbycusisCognitive DysfunctionDepression

Condition Hierarchy (Ancestors)

Hearing Loss, SensorineuralHearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental DisordersBehavioral SymptomsBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2023

First Posted

June 7, 2023

Study Start

February 8, 2023

Primary Completion

April 16, 2023

Study Completion

December 31, 2023

Last Updated

June 7, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations